Moneycontrol
Get App
Last Updated : May 14, 2019 10:54 AM IST | Source: PTI

Glenmark Pharmaceuticals gets USFDA nod for acid reflux medication

The approved products is a generic version of AstraZeneca Pharmaceuticals' Nexium delayed-release capsules.


Glenmark Pharmaceuticals on May 14 said it has received final approval from the US health regulator for generic version of AstraZeneca's Nexium, used to treat acid reflux.

Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food & Drug Administration (US FDA) for Esomeprazole Magnesium delayed-release capsules USP in the strengths of 20 mg and 40 mg, the company said in a BSE filing.

The approved products is a generic version of AstraZeneca Pharmaceuticals' Nexium delayed-release capsules.

Close

Citing IQVIA sales data, Glenmark said, Nexium delayed-release capsules, 20 mg and 40 mg achieved annual sales of around $395.1 million in the 12-month period ended March 2019.

The company said its current portfolio consists of 153 products authorised for distribution in the US and 58 ANDA's pending approval with the USFDA.

Shares of Glenmark Pharma were trading 0.46 percent higher at Rs 594.35 apiece on BSE.

Moneycontrol Ready Reckoner
Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.

Get best insights into Options Trading. Webinar by Mr. Vishal B Malkan is Live. Watch Now!

First Published on May 14, 2019 10:50 am